Canature Health released its 2026 interim report. The company's total operating revenue was 921 million yuan, and net profit attributable to the parent was 40.4053 million yuan, down 39.61% from the same period last year, a decrease of 26.5002 million yuan. Net cash inflow from operating activities was 157 million yuan, the asset-liability ratio was 60.74%, the gross margin was 41.59%, ROE was 3.19%, and diluted earnings per share was 0.07 yuan, down 44.17% year-on-year. Total asset turnover was 0.26 times, and inventory turnover was 1.81 times. The company had 22,500 shareholders, and the top ten shareholders held 45.00% of the total share capital.
Shanghai Canature EnvironmentalNet profit down 39.61% year-on-year
